M

Moderna

Develops mRNA-based medicines for health

Director, Analytical Development

Bioprocess & BiomanufacturingConfirmed live in the last 24 hours
Full-timeNorwood, MA, USA

About the Job

Requirements

  • A Ph.D. in Analytical Chemistry, Biochemistry, Pharmaceutical Sciences, Chemical Engineering, Bioengineering, or a related scientific field with 12 or more years of relevant industry experience, or an M.S. or B.S. with 18 or more years of relevant experience in analytical development, analytical technology, pharmaceutical sciences, or related areas for biologics, vaccines, or advanced therapeutic modalities.
  • Demonstrated ability to define and execute an analytical innovation or technology strategy and translate emerging science into methods and capabilities adopted in development or GMP Quality Control environments.
  • Deep scientific expertise in analytical method development, broad understanding across multiple analytical domains, and ability to assess strengths, limitations, and intended-use suitability of emerging technologies.
  • Strong understanding of analytical procedure lifecycle principles, including analytical target profiles, robustness and risk assessment, qualification or validation, method transfer, continued performance monitoring, and lifecycle change management; practical knowledge of ICH Q14 and Q2(R2) is strongly preferred.
  • Proven experience moving new analytical technologies from concept or proof of concept through implementation, including cross-functional alignment, technology transfer, validation strategy, change control, and adoption within clinical or commercial testing networks.
  • Strong knowledge of GMP, data integrity, global regulatory expectations, and inspection readiness, with scientific judgment to balance innovation, phase-appropriate development, compliance, and operational scalability.
  • Experience leading complex, matrixed initiatives across Analytical Development, QC, AST/MS&T, Process Development, Manufacturing, Quality, Regulatory, Digital, and external partners, and ability to influence senior stakeholders without relying solely on direct authority.
  • Strong external orientation and ability to build productive collaborations with technology vendors, academic groups, consortia, CROs/CDMOs, and peer organizations to identify, evaluate, and accelerate high-value analytical innovation.
  • Demonstrated success developing high-performing scientific talent and creating an environment where rigorous experimentation, learning, prioritization, and execution translate into scalable organizational capabilities.
  • Excellent scientific communication, executive presence, stakeholder management, and organizational leadership skills.

Responsibilities

  • Lead the Innovative Technology and Methodology capability within Analytical Development, establishing the vision, scientific strategy, portfolio, and roadmap for next-generation analytical methods and technologies across clinical and commercial products.
  • Build and govern an end-to-end analytical innovation pipeline that identifies unmet analytical needs, evaluates emerging technologies, prioritizes opportunities, develops proof-of-concept solutions, and advances successful technologies through development, qualification or validation strategy, transfer, and implementation.
  • Partner with Analytical Sciences, APLs, AST, and QC to translate product knowledge, control-strategy needs, method performance trends, investigations, and network pain points into prioritized innovation programs with clear analytical target profiles and intended-use requirements.
  • Drive development and modernization of analytical methodologies across separation sciences, molecular and sequencing technologies, biophysical and spectroscopic methods, bioassays, microbiology, advanced characterization, and other emerging analytical platforms appropriate to mRNA and advanced therapeutic modalities.
  • Lead method transformation across the QC network by enabling replacement, simplification, consolidation, and harmonization of legacy methods with more robust, higher-throughput, automation-ready, and scalable platform approaches where scientifically and regulatorily justified.
  • Partner with AST, QC, ATO, Quality, Regulatory, Digital, and Automation teams to establish implementation pathways for innovative methods, including bridging, transfer, validation, change management, digital integration, training, and sustained method performance across internal and external testing sites.
  • Embed science- and risk-based analytical development principles consistent with evolving global expectations, including ICH Q14 and Q2(R2), ensuring new methodologies are fit for intended purpose, appropriately robust, lifecycle-ready, and supported by a defensible regulatory strategy.
  • Establish an external innovation network across instrument and technology vendors, biotechnology companies, academic collaborators, consortia, and other external partners; scout emerging capabilities and determine where external innovation can accelerate Moderna analytical strategy.
  • Advance automation-, digital-, and data-enabled analytical methodologies in partnership with relevant functions, designing methods and workflows that reduce manual variability, improve data integrity and review efficiency, and enable scalable deployment across the analytical network.
  • Define success measures and business cases for the innovation portfolio, including improvements in method robustness, invalid/OOS/OOT rates, turnaround time, throughput, labor intensity, cost, method harmonization, and successful network adoption; use measures to prioritize investment and stop or redirect low-value efforts early.
  • Develop, coach, and inspire scientific talent while creating a culture that combines curiosity and experimentation with disciplined execution, technical rigor, cross-functional accountability, and focus on translating innovation into sustained organizational impact.
  • Work 100% onsite to support work, collaborate closely with colleagues, and contribute to site-based operations.

Desired Qualifications

  • Experience with analytical automation, high-throughput workflows, digital integration, advanced data analysis, AI/ML-enabled analytical applications, or other laboratory-of-the-future capabilities.
  • Experience with mRNA, nucleic acids, lipid nanoparticles, vaccines, biologics, or other advanced modalities, and understanding of how analytical technologies support product characterization, control strategy, comparability, stability, and manufacturing.

About the Company

Moderna

Develops mRNA-based medicines for health

Moderna develops medicines built on messenger RNA (mRNA). Its products use mRNA delivered into cells to instruct them to produce specific proteins that can prevent or treat disease, with vaccines being a primary example. In practice, a dose delivers engineered mRNA into the body, cells translate it into a target protein, and the immune system responds or the protein modulates biology to combat disease. Moderna differentiates itself through its focus on building a whole mRNA medicines platform and in-house capabilities for designing, manufacturing, and scaling mRNA therapies, including rapid development and large-scale production. Its goal is to create a new category of medicines based on mRNA that can improve how diseases are discovered, developed, and treated, ultimately improving patient outcomes.

Company size
5,001-10,000
Company stage
IPO
Headquarters
Cambridge, MA
Founded
2010

Recently Posted Jobs

Explore more opportunities at Moderna

See more jobs